Prosecution Insights
Prosecution Insights
37 pending office actions • 22 art units • 35 examiners • 0 of 37 (0%) have an AI response strategy ready • 62 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (3%) |
| §103 only | 25 (68%) |
| §102 only | 4 (11%) |
| §112 only | 1 (3%) |
| Double-patenting only | 3 (8%) |
| No statute on record | 3 (8%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HEASLEY, MEGHAN CHRISTINE | 2 | 77.4% | +32.2% |
| LEE, CHIHYI NMN | 2 | 32.1% | +57.4% |
| LOUIS, RICHARD G | 1 | 74.6% | +17.2% |
| RAGHU, GANAPATHIRAM | 1 | 73.7% | +26.2% |
| GEBREMICHAEL, BRUK A | 1 | 22.3% | +23.8% |
| GRASER, JENNIFER E | 1 | 76.6% | +23.5% |
| BRAUN, MADELINE E | 1 | 68.1% | +25.2% |
| GREEN, RICHARD R | 1 | 74.4% | +23.2% |
| ADAM, MOHAMMED SOHAIL | 1 | 65.9% | +56.6% |
| AMICK, THOMAS RUSSE | 1 | 72.8% | +31.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009608 | METHODS AND SYSTEMS FOR DETERMINING AND CORRECTING IMAGING ARTIFACTS | ROBINSON, NICHOLAS A | 26d |
| 18812628 | METHODS AND KITS FOR DIAGNOSING, ASSESSING OR QUANTITATING DRUG USE, DRUG ABUSE AND NARCOSIS, INTERNUCLEAR OPHTHALMOPLEGIA, ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), CHRONIC TRAUMATICENCEPH ALOPATHY,SCHIZOPHRENIA SPECTRUM DISORDERS AND ALCOHOL CONSUMPTION | GEBREMICHAEL, BRUK A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18702962 | ACTIVE PRESSURE RELIEVING SYSTEM | GREEN, RICHARD R | 66d overdue |
| 18548348 | BENZOXAZOLONE INHIBITORS OF INFLAMMASOMES | HEASLEY, MEGHAN CHRISTINE | 27d |
| 18749726 | Combination Therapy for Treating or Preventing Depression or Other Mood Diseases | LEE, CHIHYI NMN | 34d |
| 19129959 | CATHETER AND METHODS OF USING SAME | LOUIS, RICHARD G | — |
| 18852356 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE | RAGHU, GANAPATHIRAM | — |
| 18812628 | METHODS AND KITS FOR DIAGNOSING, ASSESSING OR QUANTITATING DRUG USE, DRUG ABUSE AND NARCOSIS, INTERNUCLEAR OPHTHALMOPLEGIA, ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), CHRONIC TRAUMATICENCEPH ALOPATHY,SCHIZOPHRENIA SPECTRUM DISORDERS AND ALCOHOL CONSUMPTION | GEBREMICHAEL, BRUK A | — |
| 18671007 | Non-Toxin Antigens For Clostridioides Difficile Vaccine | GRASER, JENNIFER E | — |
| 18710037 | METHOD OF TREATING CANCER ASSOCIATED WITH RAS MUTATION | BRAUN, MADELINE E | — |
| Art Unit | Apps |
|---|---|
| 1628 | 4 |
| 3771 | 2 |
| 1626 | 2 |
| 1622 | 2 |
| 3798 | 2 |
| 1624 | 2 |
| 1636 | 2 |
| 1627 | 2 |
| 1642 | 2 |
| 1617 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19129959 | CATHETER AND METHODS OF USING SAME | LOUIS, RICHARD G | 3771 | §103 | Non-Final OA | — | Pending | May 14, 2025 |
| 18852356 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE | RAGHU, GANAPATHIRAM | — | §103 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18812628 | METHODS AND KITS FOR DIAGNOSING, ASSESSING OR QUANTITATING DRUG USE, DRUG ABUSE AND NARCOSIS, INTERNUCLEAR OPHTHALMOPLEGIA, ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), CHRONIC TRAUMATICENCEPH ALOPATHY,SCHIZOPHRENIA SPECTRUM DISORDERS AND ALCOHOL CONSUMPTION | GEBREMICHAEL, BRUK A | 3715 | DP | Final Rejection | — | Pending | Aug 22, 2024 |
| 18671007 | Non-Toxin Antigens For Clostridioides Difficile Vaccine | GRASER, JENNIFER E | 1645 | §102 | Non-Final OA | — | Pending | May 22, 2024 |
| 18710037 | METHOD OF TREATING CANCER ASSOCIATED WITH RAS MUTATION | BRAUN, MADELINE E | — | §103 | Non-Final OA | — | Pending | May 14, 2024 |
| 18702962 | ACTIVE PRESSURE RELIEVING SYSTEM | GREEN, RICHARD R | 3647 | §103 | Non-Final OA | 66d overdue | Pending | Apr 19, 2024 |
| 18684563 | TREATMENT COMPOSITIONS AND METHODS | HEASLEY, MEGHAN CHRISTINE | 1626 | §103 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18294467 | NERVE COUPLER AND METHOD FOR USE OF THE SAME | ADAM, MOHAMMED SOHAIL | 3771 | §103 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18417617 | COMPOSITIONS AND METHODS FOR SPATIAL AND TEMPORAL CONTROL OF NEUROTROPHIC GROWTH FACTOR EXPRESSION | AMICK, THOMAS RUSSE | 1638 | §102 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18390242 | COMPOSITIONS AND METHOD FOR TREATING GUT PERMEABILITY CAUSED BY HYDROGEN SULFIDE PRODUCING BACTERIA | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18478342 | SYSTEMS AND METHODS FOR HISTOTRIPSY IMMUNOSENSITIZATION | DEUTSCH, TAYLOR M | 3798 | §103 | Final Rejection | 40d | Pending | Sep 29, 2023 |
| 18372662 | MUSCARINIC M2 RECEPTOR BLOCKADE TO DELAY OR PREVENT ONSET OF PROGRESSIVE MEMORY DECLINE | BORALSKY, LUKE ALAN | 1624 | DP | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18548348 | BENZOXAZOLONE INHIBITORS OF INFLAMMASOMES | HEASLEY, MEGHAN CHRISTINE | 1626 | §103 | Non-Final OA | 27d | Pending | Aug 30, 2023 |
| 18271618 | METHOD OF GENE DELIVERY TO RETINAL ASTROCYTES | BRETZ, COREY LANE | 1635 | §103 | Final Rejection | 3d overdue | Pending | Jul 10, 2023 |
| 18271631 | GENETIC THERAPY FOR GLAUCOMA AND OPTIC NEUROPATHIES | YU, DELPHINUS DOU YI | 1636 | §112 | Non-Final OA | — | Pending | Jul 10, 2023 |
| 18347811 | Compositions And Methods For Treating Gulf War Illness | MOTEVALLI, OROD | 1628 | Other | Non-Final OA | 37d overdue | Pending | Jul 06, 2023 |
| 18034649 | DRUGS TARGETING INFLAMMATION FOR THE TREATMENT OF OSTEOARTHRITIS AND OTHER INFLAMMATORY DISEASES | HASTINGS, ALISON AZAR | 1627 | §103 | Non-Final OA | 66d overdue | Pending | Apr 28, 2023 |
| 18301093 | Human Adipose-Derived Stem Cell Exosomes And Their Packaging For Use At Room Temperature | CONNORS, ALEXANDRA F | 1634 | §103 | Non-Final OA | 29d | Pending | Apr 14, 2023 |
| 18186869 | METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS | STONEBRAKER, ALYSSA RAE | 1642 | Other | Non-Final OA | — | Pending | Mar 20, 2023 |
| 18043163 | HYDROXYNORKETAMINE COMPOUNDS AND METHODS OF USE THEREOF | RAO, PADMAJA S | 1627 | §103 | Non-Final OA | — | Pending | Feb 27, 2023 |
| 18164699 | NOVEL EFFICACIOUS MICRORNA-30C ANALOGS REDUCE APOLIPOPROTEIN B SECRETION IN HUMAN LIVER CELLS | CHONG, KIMBERLY | 1636 | §103 | Final Rejection | — | Pending | Feb 06, 2023 |
| 18015169 | BIOFLUID-BASED PROTEIN AND MIRNA BIOMARKERS FOR NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY | MCCOLLUM, ANDREA K | 1674 | §102 | Non-Final OA | 60d | Pending | Jan 09, 2023 |
| 18008605 | USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING INFLAMMATORY CONDITIONS | RODRIGUEZ, RAYNA B | 1628 | §103 | Non-Final OA | 66d overdue | Pending | Dec 06, 2022 |
| 17925775 | Methods and Compositions for Treating Pain While Minimizing the Risk of Opioid Addiction | SOROUSH, LAYLA | 1622 | §103 | Non-Final OA | 35d overdue | Pending | Nov 16, 2022 |
| 17946094 | METHODS FOR DNA-DEPENDENT TARGETING OF A CELL PERMEANT ANTIBODY | GODDARD, LAURA B | 1642 | Other | Non-Final OA | 2d overdue | Pending | Sep 16, 2022 |
| 17800208 | EGFR INHIBITION TRIGGERS AN ADAPTIVE RESPONSE BY CO-OPTING ANTIVIRAL SIGNALING PATHWAYS IN LUNG CANCER | LEE, CHIHYI NMN | 1628 | §103 | Non-Final OA | — | Pending | Aug 16, 2022 |
| 17767709 | RAPID MANUFACTURING OF ABSORBENT SUBSTRATES FOR SOFT, CONFORMABLE SENSORS AND CONDUCTORS | LEE, DAVINA EN-YIN | 3794 | §103 | Non-Final OA | — | Pending | Apr 08, 2022 |
| 17625059 | TREATMENT OF PULMONARY FIBROSIS USING INHIBITORS OF NEU1 SIALIDASE | COLEMAN, BRENDA LIBBY | 1624 | §102 | Non-Final OA | — | Pending | Jan 05, 2022 |
| 17276213 | VECTORS EXPRESSING COLOR AND SELECTABLE MARKERS | SPENCE, JENNIFER SUZANNE | 1633 | §103 | Final Rejection | 30d overdue | Pending | Mar 15, 2021 |
| 19027952 | Stereotactic Multifocal Recording And Stimulation Device And Methods Of Use | SCHAETZLE, KENNEDY | — | DP | Final Rejection | — | Pending | Jan 17, 2025 |
| 18777012 | Systems And Methods For Communicating With Patient In Magnetic Resonance Imaging Device | COOK, CHRISTOPHER L | 3797 | §103 | Non-Final OA | 83d | Pending | Jul 18, 2024 |
| 18749726 | Combination Therapy for Treating or Preventing Depression or Other Mood Diseases | LEE, CHIHYI NMN | 1628 | §103 | Final Rejection | 34d | Pending | Jun 21, 2024 |
| 18502774 | Needle Assembly With Integrated Curvature Mechanism | NICHOLS, CHARLES W | 3783 | §103 | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18009608 | METHODS AND SYSTEMS FOR DETERMINING AND CORRECTING IMAGING ARTIFACTS | ROBINSON, NICHOLAS A | 3798 | §101 | Final Rejection | 26d | Pending | Dec 09, 2022 |
| 17779865 | METHODS OF USING SOLUBLE SOLID DISPERSIONS OF RIFAXIMIN | MEYERS, ELIZABETH ANNE | 1617 | §103 | Non-Final OA | 13d | Pending | May 25, 2022 |
| 17711782 | Ear Stent And Methods Of Using Same | BLASS, PARIS MARIE | 3774 | §103 | Non-Final OA | 29d | Pending | Apr 01, 2022 |
| 17639265 | LIPOSOMAL TROPONOID COMPOUND FORMULATIONS | PIPIC, ALMA | 1617 | §103 | Non-Final OA | — | Pending | Feb 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial